CytomX Therapeutics is set to release important trial results for its colorectal cancer drug Varseta-M in January 2027. Recent adjustments in dosing and steroid use have lowered severe diarrhea side effects, but confirmation is pending. The competitive market for antibody-drug conjugates in colorectal cancer is intensifying, making this readout crucial for CytomX's future. Additional data on Varseta-M combinations and other therapies are expected in the first half of 2027.
CytomX Therapeutics is the subject, with this Pluang market snapshot for health-sector US stocks as of Nov 13, 2026 18:41 WIB: Out of 150 stocks, 93 rose and 49 fell. Among notable movers, NVAX rose 3.08% to USD 9.03 with a strong buy interest of 99% on Pluang and a typical hold time of 60 days, contrasting with BNGO which fell 2.88% to USD 1.01 and saw a nearly even sell/buy split. ASND also gained 2.95% to USD 274.96, with a hold time close to NVAX's at 58 days.
Investec Bank Plc, acting as an exempt principal trader and advisor to DBAY Advisors Limited, disclosed the sale of 25,000 ordinary shares of Logistics Development Group Plc on November 12, 2026. The shares were sold at a price of 23 per unit. There ...
Investec Bank Plc, acting as advisor and joint broker to Advanced Medical Solutions Group Plc, disclosed public dealings in the company's ordinary shares on November 12, 2026. The bank purchased 345,456 shares at prices between 282.561 and 283 pence ...
Ondas Holdings increased its 2026 revenue target to at least $550 million and projects $1.1 billion in sales for 2027, driven by strong growth and planned production expansion. The company reported Q3 revenue of $167.49 million, surpassing estimates ...
The Philippines solar energy market is projected to grow from 5.43 GW in 2026 to 23.35 GW by 2032, with a CAGR of 27.46%. Growth is fueled by declining costs of solar panels and installation, government-backed renewable energy auctions, and increasin...
Equinor ASA shares will trade ex-dividend on the Oslo Stock Exchange starting November 13, 2026, for the second quarter of 2026. The declared dividend amount is $0.39 per share, payable in USD. This means investors buying shares from this date will n...
